Clinical Trial Update: Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Bayer evaluating contrast-enhanced MRI in patients with brain neoplasms; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Snippet

Sponsor: Bayer | Conditions: Neoplastic CNS Lesions | Phase 4 | Status: COMPLETED